WCLC 2025 - Posters & ePosters-EP.12.58 Feasibility of Aumolertinib Followed by SRT in EGFR+ NSCLC Patients With Intracranial Oligo-Progression: A Phase II, Prospective Study

EP.12.58 Feasibility of Aumolertinib Followed by SRT in EGFR+ NSCLC Patients With Intracranial Oligo-Progression: A Phase II, Prospective Study

Asset Subtitle

Jiayan Chen

Meta Tag

Speaker Jiayan Chen

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy